FDA NEWS

Teva receives FDA approval for generic Risperdal - BusinessWeek
Teva Pharmaceutical Industries Ltd. said Monday it received Food and Drug Administration approval for a generic version of Johnson & Johnson's blockbuster anti-psychotic drug Risperdal. Israel-based Teva was the first company to ask for generic
Source: www.businessweek.com

Introgen shares rise on cancer drug filings - Forbes
Shares of Introgen Therapeutics Inc. rose Monday after the biotechnology company said it asked U.S. and European regulators to approve its drug Advexin as a head and neck cancer treatment. The stock gained 4 cents, or 2.7 percent, to reach $1.55
Source: www.forbes.com

Generic version of Risperdal gains FDA OK - CNBC
Teva won approval for a generic version of the popular anti-psychotic drug NEW YORK - Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first
Source: www.cnbc.com

Par Pharmaceutical Receives Final Approval to Market Generic Marinol - Phramalive.com
WOODCLIFF LAKE, N.J., June 30, 2008 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for dronabinol, a
Source: www.pharmalive.com

Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol - MSN MoneyCentral
LAVAL, QC, June 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that the Company has received a response from the U.S. Food and Drug Administration (FDA) regarding its most recent appeal of the decision in the
Source: news.moneycentral.msn.com

FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial - PR Inside
- The U.S. Food and Drug Administration ("FDA") today announced the approval of EVOLENCE(R) for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCE(R) is a new advanced collagen-based structural dermal
Source: www.pr-inside.com

Teva receives FDA approval for generic anti-psychotic drug Risperdal - Canada East
NEW YORK - Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version. Israel-based Teva received U
Source: www.canadaeast.com

Teva Receives First U.S. Approval for Generic Risperdal(R) Tablets - MSN MoneyCentral
Teva Pharmaceutical Industries Ltd. TEVA announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Janssen's antipsychotic agent
Source: news.moneycentral.msn.com

Analysts: Key Genentech drug could top 2Q forecast - Forbes
Shares of Genentech Inc. rose Monday as analysts said industry drug sales data showed the biotechnology company's cancer drug Avastin could top second-quarter sales forecasts. Shares of the South San Francisco, Calif.-based company gained $3.18, or 4
Source: www.forbes.com